High Expression of CUL9 Is Prognostic and Predictive for Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer
We evaluated the clinical implications of CUL9 expression on the prognosis and the predictive value for adjuvant chemotherapy in colon cancer. A total of 1078 consecutive patients treated with radical resection from 2008 to 2012 were included. Formalin-fixed, paraffin-embedded specimens were used as...
Main Authors: | Peng Zheng, Yang Lv, Yihao Mao, Feifan Shen, Zhiyuan Zhang, Jiang Chang, Shanchao Yu, Meiling Ji, Qingyang Feng, Jianmin Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/16/3843 |
Similar Items
-
Adjuvant Chemotherapy for Stage III Colon Cancer
by: Julien Taieb, et al.
Published: (2020-09-01) -
Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa
by: Sarah Xinhui Tan, et al.
Published: (2023-07-01) -
Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
by: Huabin Hu, et al.
Published: (2020-12-01) -
Real-life experiences and barriers to adjuvant chemotherapy in Saudi patients with advanced stage II and stage III colon cancer
by: Mesnad S Alyabsi, et al.
Published: (2024-01-01) -
Association between diabetes and adjuvant chemotherapy implementation in patients with stage III colorectal cancer
by: Rieko Kanehara, et al.
Published: (2022-10-01)